Beam Therapeutics Inc. short interest in 2025
In 2025, Beam Therapeutics Inc.'s disclosed short interest ran from 13.03% of shares outstanding on 15 Jan 2025 to 20.00% on 31 Dec 2025, a change of +6.97 percentage points. The year's high was 26.86% on 15 Aug 2025 and its low 11.16% on 14 Feb 2025, averaging 19.85% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.66 days on 31 Dec 2025. Full history: Beam Therapeutics Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 13.03% (15 Jan 2025)
- End of year
- 20.00% (31 Dec 2025)
- Change
- +6.97 pp
- High
- 26.86% (15 Aug 2025)
- Low
- 11.16% (14 Feb 2025)
- Average
- 19.85%
- Highest days to cover
- 15.66 (31 Dec 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 13.03% | 7.37 | results (8-K) |
| 31 Jan 2025 | 12.09% | 11.21 | |
| 14 Feb 2025 | 11.16% | 7.34 | |
| 28 Feb 2025 | 12.07% | 6.27 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 14.69% | 4.43 | |
| 31 Mar 2025 | 17.80% | 6.68 | |
| 15 Apr 2025 | 22.74% | 5.41 | |
| 30 Apr 2025 | 19.15% | 10.76 | |
| 15 May 2025 | 20.73% | 9.09 | 10-Q filed, results (8-K) |
| 30 May 2025 | 21.04% | 13.65 | |
| 13 Jun 2025 | 21.61% | 12.10 | |
| 30 Jun 2025 | 23.94% | 11.84 | |
| 15 Jul 2025 | 23.53% | 8.68 | |
| 31 Jul 2025 | 24.33% | 11.05 | |
| 15 Aug 2025 | 26.86% | 10.69 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 25.19% | 11.50 | |
| 15 Sep 2025 | 25.21% | 7.34 | |
| 30 Sep 2025 | 21.14% | 8.52 | |
| 15 Oct 2025 | 20.19% | 8.41 | |
| 31 Oct 2025 | 19.54% | 7.61 | |
| 14 Nov 2025 | 20.25% | 8.66 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 20.65% | 10.36 | |
| 15 Dec 2025 | 19.50% | 10.94 | |
| 31 Dec 2025 | 20.00% | 15.66 |
See also: Beam Therapeutics Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.